Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Physical Therapy|July 17, 2023
The Impact of Nordic Pole Walk Advice Alone or in Combination With Exercise Strategies on Daily Physical Activity in Patients With Intermittent Claudication: A Randomized Clinical TrialAnna Sandberg, Joakim Nordanstig, Åsa Cider, et al.
Endocrinology, Diabetes & Metabolism|July 19, 2021
A population-adjusted indirect comparison of cardiovascular benefits of once-weekly subcutaneous semaglutide and dulaglutide in the treatment of patients with type 2 diabetes, with or without established cardiovascular diseaseLyndon Marc Evans, Linda Mellbin, Pierre Johansen, et al.
Advances in Therapy|April 20, 2020
Evaluating the Long-Term Cost-Effectiveness of Once-Weekly Semaglutide Versus Once-Daily Liraglutide for the Treatment of Type 2 Diabetes in the UKPierre Johansen, Barrie Chubb, Barnaby Hunt, et al.
Journal of Clinical Medicine|August 26, 2023
Cost-Effectiveness of Exercise Therapy in Patients with Intermittent Claudication-A Comparison of Supervised Exercise, Home-Based Structured Exercise, and Walk Advice from the SUNFIT TrialHildigunnur Ulfsdottir, Maria Bäck, Åsa Cider, et al.
European Journal of Cardiovascular Nursing|August 2, 2022
Effectiveness of supervised exercise, home-based exercise, or walk advice strategies on walking performance and muscle endurance in patients with intermittent claudication (SUNFIT trial): a randomized clinical trialAnna Sandberg, Maria Bäck, Åsa Cider, et al.
Diabetes, Obesity & Metabolism|June 3, 2017
Projected long-term outcomes in patients with type 1 diabetes treated with fast-acting insulin aspart vs conventional insulin aspart in the UK settingDavid Russell-Jones, Simon R Heller, Sarah Buchs, et al.
Current Medical Research and Opinion|December 24, 2016
Understanding bolus insulin dose timing: the characteristics and experiences of people with diabetes who take bolus insulinWilliam V Tamborlane, Kathryn M Pfeiffer, Meryl Brod, et al.
The Journal of Clinical Endocrinology and Metabolism|August 23, 2020
Efficacy of Once-Weekly Semaglutide vs Empagliflozin Added to Metformin in Type 2 Diabetes: Patient-Level Meta-analysisIldiko Lingvay, Matthew S Capehorn, Andrei-Mircea Catarig, et al.
ACS Applied Materials & Interfaces|February 4, 2014
Dielectric and other properties of polyimide aerogels containing fluorinated blocksMary Ann B Meador, Emily McMillon, Anna Sandberg, et al.
Diabetes, Obesity & Metabolism|April 1, 2020
Semaglutide improves health-related quality of life versus placebo when added to standard of care in patients with type 2 diabetes at high cardiovascular risk (SUSTAIN 6)Esteban Jódar, Marie Michelsen, William Polonsky, et al.
Pageof 3